Cytokinetics, Incorporated (CYTK) Operating income 2016–2025
Cytokinetics, Incorporated (CYTK) annual operating income history from SEC filings — each fiscal year as reported.
-$612.3MFY2025 · since FY2016: $18.7M → -$612.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$612.3M | -14.2% |
| FY2024 | -$536.2M | -8.1% |
| FY2023 | -$496.2M | -53.1% |
| FY2022 | -$324.2M | -74.0% |
| FY2021 | -$186.3M | -98.3% |
| FY2020 | -$93.9M | +5.0% |
| FY2019 | -$98.9M | -11.2% |
| FY2018 | -$88.9M | +21.6% |
| FY2017 | -$113.4M | -706.8% |
| FY2016 | $18.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice